| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc. (ELVN) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. ELVN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 890.4K | $35.60M | - | |
| CEO | 875.0K | $34.98M | - | |
| Other | 740.2K | $29.59M | - | |
| COO | 215.3K | $8.61M | - | |
| CFO | 92.1K | $3.68M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | Collins Helen Louise | Chief Medical Officer | Sale+OE | 5,000 | $47.67 | $238,352.42 | -5.7% | - | - | |
| Mar 10, 2026 | Collins Helen Louise | Chief Medical Officer | Sale+OE | 40,000 | $30.07 | $1,202,637.98 | -44.4% | - | - | |
| Feb 6, 2026 | Lyssikatos Joseph P53 | Chief Scientific Officer | Sell | 5,000 | $29.04 | $145,219.00 | -0.7% | - | - | |
| Jan 9, 2026 | Patel Anish55 | Chief Operating Officer | Sell | 48,300 | $27.99 | $1,351,762.20 | -10.1% | +75.3% | - | |
| Jan 9, 2026 | Lyssikatos Joseph P53 | Chief Scientific Officer | Sell | 132,500 | $26.23 | $3,476,013.95 | -3.8% | +75.3% | - | |
| Jan 9, 2026 | Heyman Richard A.74 | Director | Sell | 13,920 | $25.02 | $348,280.95 | -14.8% | +75.3% | - | |
| Dec 19, 2025 | Lyssikatos Joseph P53 | Chief Scientific Officer | Sell | 5,000 | $16.84 | $84,206.00 | -0.6% | +78.1% | - | |
| Dec 8, 2025 | Patel Anish55 | Chief Operating Officer | Sell | 6,663 | $21.02 | $140,072.86 | -1.2% | +45.1% | - | |
| Nov 19, 2025 | Lyssikatos Joseph P53 | Chief Scientific Officer | Sell | 12,500 | $22.33 | $279,154.78 | -0.7% | +18.2% | - | |
| Nov 17, 2025 | Kintz Samuel54 | President And CEO | Sell | 12,500 | $21.82 | $272,738.75 | -1.4% | +20.1% | - |